United States· US:33342-124_deb9183f-bf62-4547-9c33-b6d8af55ddd9

Aripiprazole

A aripiprazole product containing aripiprazole, registered in United States by Macleods Pharmaceuticals Limited. The same ATC class is registered in 18 of our 19 countries.

ATC N05AX12US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedAripiprazoleATCN05AX12REGISTER NO.US:33342-124_deb9183f…PACKS LISTED6CHECKEDSeptember 27, 2026

Where it is registered

Aripiprazole is registered in 18 of 19 countries.

Countries holding a registration under ATC N05AX12 (aripiprazole), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 11 of them publish a price we can compare per daily dose

Aripiprazole · ATC N05AX12

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of aripiprazole costs, country by country.

Normalised to the WHO defined daily dose (15 mg), the median price runs from $0.15 in United States to $3.12 in Switzerland — a ×21 gap.

  • United States: $0.15 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Aripiprazole · price per daily dose (15 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$3.12
  • IT Italy$1.19
  • FR France$1.06
  • US United States$0.15 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
ARIPIPRAZOLE
Manufacturer
Macleods Pharmaceuticals Limited
Country
United States (US)
ATC code
N05AX12
ATC class
Aripiprazole
Defined daily dose
15 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 6

  • ndc11
    33342-124-07
  • ndc11
    33342-124-11
  • ndc11
    33342-124-12
  • ndc11
    3334212407
    30 TABLET in 1 BOTTLE (33342-124-07)
  • ndc11
    3334212411
    100 TABLET in 1 BOTTLE (33342-124-11)
  • ndc11
    3334212412
    10 BLISTER PACK in 1 CARTON (33342-124-12) / 10 TABLET in 1 BLISTER PACK

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

468 interactions on record for aripiprazole.

Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Aripiprazole · interactions on record

468 records

  • 11 severe
  • 339 moderate
  • 2 minor
  • 67 info

Most severe, free to view

  • MetoclopramideA03FA01severe
  • ClotrimazoleA01AB18moderate
  • CimetidineA02BA01moderate
  • FamotidineA02BA03moderate

49 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Aripiprazole in 18 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All aripiprazole products

Authorised across Europe · EMA

The same active substance is authorised in 31 EEA countries. Names it is sold under:

  • Austria · 300 Mg, Arileto
  • Belgium · Aripiprazol Krka, Aripiprazol Sandoz
  • Bulgaria · Абизол, Арикоган
  • Cyprus · Aripiprazole Aurobindo, Aripiprazole Krka
  • Czechia · Abyca, Aricogan
  • Germany · Aripipan, Aripiprazol 1 A Pharma
  • Denmark · Aripiprazol Krka, Aripiprazol Stada
  • Estonia · Aregzilap, Aripiprazole Stada
  • Spain · Abik, Abilium
  • Finland · Aripiprazol Krka, Aripiprazol Stada
  • France · Aripiprazole Almus, Aripiprazole Arrow
  • United Kingdom (Northern Ireland) · Aripiprazole, Aripiprazole Accord-Uk
  • Greece · Abelfiz, Aripility
  • Croatia · Aregzilap, Aripiprazol Pliva
  • Hungary · Aripiprazol Sandoz, Aripiprazol Stada
  • Ireland · Aripiprazole Brillpharma (Ireland), Aripiprazole Clonmel
  • Iceland · Abilify, Abilify Maintena
  • Italy · Aberipra, Aripiprazolo Alter
  • Liechtenstein · Abilify, Abilify Maintena
  • Lithuania · Aregzilap, Aripiprazole Stada
  • Luxembourg · Aripiprazol Ratiopharm, Aripiprazole Eg
  • Latvia · Aregzilap, Aripiprazole Acino
  • Malta · Aripiprazol Generis, Aripiprazole Ascend
  • Netherlands · Aribit Odt, Aricogan
  • Norway · Abilify, Abilify Maintena
  • Poland · Abilium, Apiprax
  • Portugal · Aripiprazol Altedron, Aripiprazol Alter
  • Romania · Aripiprazol Accord Healthcare, Aripiprazol Stada
  • Sweden · Aregzilap, Aripiprazol Krka
  • Slovenia · Aripiprazol Accord Healthcare, Aripiprazol Stada
  • Slovakia · Aripiprazol Sandoz, Aripiprazol Stada

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e1eb352a-2aa7-4728-ba1c-85c9b23ec222
GET /v1/drugs/e1eb352a-2aa7-4728-ba1c-85c9b23ec222?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "10",
  "substance": "ARIPIPRAZOLE",
  "productndc": "33342-124",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA204111",
  "marketing_category": "ANDA"
}

See everything about aripiprazole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.